☆ 4.2 Article

Treatment regimens in patients over 64 years with acute myeloid leukaemia: a retrospective single-institution, multi-site analysis

HEMATOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Hematology

Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN

Hartmut Doehner et al.

Summary: The 2010 and 2017 editions of the European LeukemiaNet recommendations for AML diagnosis and management are widely recognized. There have been major advances in our understanding of AML, including disease classification updates, improvements in genomic diagnostics, and the development of new therapeutic agents. This update includes a revised genetic risk classification, response criteria, and treatment recommendations.

BLOOD (2022)

添加到收藏夹

Article Oncology

Validation of the fitness criteria for the treatment of older patients with acute myeloid leukemia: A multicenter study on a series of 699 patients by the Network Rete Ematologica Lombarda (REL)

Erika Borlenghi et al.

Summary: This study validated the application of fitness criteria in treatment decisions for older patients with acute myeloid leukemia, showing high concordance between fitness criteria and actual treatment received, as well as an independent predictive role of fitness on survival. Different treatment strategies had significant effects on patient survival in different fitness categories.

JOURNAL OF GERIATRIC ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Acute Myeloid Leukemia, Version 2.2021 Featured Updates to the NCCN Guidelines

Daniel A. Pollyea et al.

Summary: The NCCN Guidelines for Acute Myeloid Leukemia provide recommendations for the diagnosis and treatment of adults with AML based on clinical trials that have led to significant improvements in treatment. Recent updates focus on familial genetic alterations, treatment strategies for low-risk and favorable-risk AML, venetoclax-based therapies, and considerations for patients who prefer not to receive blood transfusions.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

添加到收藏夹

Article Hematology

Multisite 11-year experience of less-intensive vs intensive therapies in acute myeloid leukemia

Mohamed L. Sorror et al.

Summary: The study found that less-intensive induction therapies in older patients with AML were associated with higher mortality risks, but after adjusting for age, physician-assigned KPS, and chance of cure, mortality risks and QOL were similar. Patients receiving less-intensive therapies had shorter lengths of hospitalization. Randomized trials are needed to better assess the value of less-intensive and intensive therapies in older or medically infirm patients.

BLOOD (2021)

添加到收藏夹

Article Hematology

Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy

Raphael Itzykson et al.

Summary: This study identified genetic mutations in AML patients that independently predict overall survival, providing a simple and robust prognostic model. By combining cytogenetic risk and mutations in specific genes, patients can be categorized into different prognostic tiers.

BLOOD (2021)

添加到收藏夹

Review Oncology

Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges

Nicholas J. Short et al.

CANCER DISCOVERY (2020)

添加到收藏夹

Article Medicine, General & Internal

Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

C. D. DiNardo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Hematology

Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges

Rory M. Shallis et al.

BLOOD REVIEWS (2019)

添加到收藏夹

Article Oncology

Acute Myeloid Leukemia, Version 3.2019

Martin S. Tallman et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

添加到收藏夹

Review Oncology

Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review

Jill A. Bell et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Burden of Acute Myeloid Leukemia Among Older, Newly Diagnosed Patients: Retrospective Analysis of Data From the 2010-2012 Medicare Limited Data Set

Naomi C. Sacks et al.

CLINICAL THERAPEUTICS (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Advancements in the management of medically less-fit and older adults with newly diagnosed acute myeloid leukemia

Laura C. Michaelis et al.

EXPERT OPINION ON PHARMACOTHERAPY (2018)

添加到收藏夹

Article Hematology

Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey

Pierre Bories et al.

HAEMATOLOGICA (2018)

添加到收藏夹

Article Hematology

Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey

Pierre Bories et al.

HAEMATOLOGICA (2018)

添加到收藏夹

Review Hematology

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Hartmut Doehner et al.

BLOOD (2017)

添加到收藏夹

Review Oncology

Pathways and mechanisms of venetoclax resistance

Prithviraj Bose et al.

LEUKEMIA & LYMPHOMA (2017)

添加到收藏夹

Article Hematology

Epidemiological, genetic, and clinical characterization by age of newly diagnosed acute myeloid leukemia based on an academic population-based registry study (AMLSG BiO)

Gabriele Nagel et al.

ANNALS OF HEMATOLOGY (2017)

添加到收藏夹

Review Hematology

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber et al.

BLOOD (2016)

添加到收藏夹

Article Oncology

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

Marina Konopleva et al.

CANCER DISCOVERY (2016)

添加到收藏夹

Article Hematology

International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Herve Dombret et al.

BLOOD (2015)

添加到收藏夹

Review Medicine, General & Internal

Acute Myeloid Leukemia

Hartmut Doehner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

添加到收藏夹

Article Oncology

Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)

Jakob R. Passweg et al.

LEUKEMIA & LYMPHOMA (2014)

添加到收藏夹

Article Hematology

Survival for older patients with acute myeloid leukemia: a population-based study

Betul Oran et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)

添加到收藏夹

Article Oncology

Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Hagop M. Kantarjian et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

添加到收藏夹

Article Hematology

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML

Sabine Kayser et al.

BLOOD (2011)

添加到收藏夹

Article Hematology

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

Gunnar Juliusson et al.

BLOOD (2009)

添加到收藏夹

Article Hematology

Age and acute myeloid leukemia

FR Appelbaum et al.

BLOOD (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.